数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

股本结构

单位:万股
公告日期 2024-03-13 2024-03-13 2024-01-30 2024-03-13 2023-11-08 2023-11-08
证券总股本 3775.69 3745.69 3743.90 2038.66 2017.74 2006.18
普通股本 3775.69 3745.69 3743.90 2038.66 2017.74 2006.18
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2024-03-05 2024-02-15 2024-01-18 2023-12-31 2023-11-06 2023-09-30
注释:中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本(万股) 变动后优先股(万股) 变动原因 变动日期
2024-03-13 3775.69 未披露 定期报告 2024-03-05
2024-03-13 3745.69 未披露 定期报告 2024-02-15
2024-01-30 3743.90 未披露 定期报告 2024-01-18
2024-03-13 2038.66 未披露
更多>>
From December 31,2022 to December 31,2023 Vesting of restricted stock units Sale of common stock net of issuance costs of $76 Issuance of common stock in connection with employee stock purchase plan
2023-12-31
2023-11-08 2017.74 未披露 定期报告 2023-11-06
2023-11-08 2006.18 未披露
更多>>
From June 30, 2023 to September 30, 2023 Vesting of restricted stock units
2023-09-30
2023-08-14 2006.00 未披露 定期报告 2023-08-08
2023-08-14 2004.44 未披露
更多>>
From March 31, 2023 to June 30, 2023 Vesting of restricted stock units Sales of common stock, net of issuance costs of $65 Issuance of common stock in connection with employee stock purchase plan
2023-06-30
2023-05-11 1960.15 未披露 定期报告 2023-05-07
2023-04-27 1958.20 未披露 定期报告 2023-04-11
2023-05-11 1957.31 未披露
更多>>
From December 31, 2022 to March 31, 2023 Vesting of restricted stock units
2023-03-31
2023-03-23 1957.31 未披露 定期报告 2023-03-20
2023-03-23 1955.67 未披露
更多>>
From December 31, 2021 to December 31, 2022 Sale of common stock,net of issuance costs of $2,449 Issuance of ESPP shares Vesting of restricted stock units Issuance of shares in connection with acquisition
2022-12-31
2022-11-07 753.49 未披露 定期报告 2022-11-02
2022-10-27 753.27 未披露
更多>>
On October 27, 2022 (the “Effective Date”), Solid Biosciences Inc. (the “Company”) filed a Certificate of Amendment to the Company’s Certificate of Incorporation with the Secretary of State of the State of Delaware (the “Certificate of Amendment”), which effected, as of 5:00 p.m. Eastern Time, on the Effective Date, a one-for-15 reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding common stock, $0.001 par value per share (the “Common Stock”).
2022-10-28
2022-08-11 11298.98 未披露 定期报告 2022-08-08
2022-08-11 11296.47 未披露
更多>>
From March 31, 2022 to June 30, 2022 Vesting of restricted stock units Issuance of ESPP shares
2022-06-30
2022-04-28 11281.19 未披露 定期报告 2022-04-11
2022-04-27 11278.13 未披露
更多>>
From December 31, 2021 to March 31, 2022 Vesting of restricted stock units
2022-03-31
2022-03-14 11047.30 未披露 定期报告 2022-02-16
2022-03-14 11034.03 未披露
更多>>
From December 31, 2020 to December 31, 2021 Sale of common stock, net of issuance costs of $8,872 Exercise of common stock options Issuance of ESPP shares Vesting of restricted stock units Forfeiture of restricted stock awards Unrealized loss on available-for-sale securities
2021-12-31
2021-11-03 11029.56 未披露
更多>>
From June 30, 2021 to September 30, 2021 Exercise of stock options Forfeiture of restricted stock awards
2021-09-30
2021-08-16 11029.70 未披露 定期报告 2021-08-10
2021-08-16 11029.60 未披露
更多>>
From March 31, 2021 to June 30, 2021 Exercise of stock options Vesting of restricted stock units Forfeiture of restricted stock awards
2021-06-30
2021-04-28 11029.73 未披露 定期报告 2021-04-15
2021-05-14 11028.86 未披露
更多>>
From December 31, 2020 To March 31, 2021 Sale of common stock, net of issuance costs of $8,872,000 Exercise of stock options Vesting of restricted stock units Forfeiture of restricted stock awards
2021-03-31
2021-03-23 10687.77 未披露
更多>>
1.Common stock offered by the company 21,739,131 shares. 2.The number of shares of common stock to be outstanding after this offering is based on 85,138,567 shares of common stock outstanding as of March 15, 2021.
2021-03-23
2021-03-18 8513.86 未披露 定期报告 2021-03-15
2021-03-15 8513.04 未披露 定期报告 2021-02-16
2021-03-15 8489.40 未披露
更多>>
From December 31, 2019 to December 31, 2020 Sale of common stock, net of issuance costs of $3,790 Issuance of common stock, to a related party, in connection with the Stock Purchase Agreement Vesting of restricted stock units Forfeiture of restricted stock awards
2020-12-31
2020-11-05 6044.93 未披露 定期报告 2020-11-01
2020-11-05 4617.85 未披露
更多>>
From June 30, 2020 to September 30, 2020 Vesting of restricted stock units Forfeiture of restricted stock awards
2020-09-30
2020-08-06 4610.18 未披露 定期报告 2020-08-01
2020-08-06 4606.84 未披露
更多>>
From March 31, 2020 to June 30, 2020 Forfeiture of restricted stock awards
2020-06-30
2020-05-07 4607.07 未披露
更多>>
From December 31, 2019 to March 31, 2020 Vesting of restricted stock units Forfeiture of restricted stock awards
2020-03-31
2020-03-12 4606.80 未披露 定期报告 2020-02-15
2020-03-12 4598.76 未披露
更多>>
From December 31, 2018 to December 31, 2019 Sale of common stock, net of issuance costs of $2,102 Sale of pre-funded warrants Forfeiture of restricted stock awards
2019-12-31
2019-11-12 4598.76 未披露 定期报告 2019-11-01
2019-11-12 4599.89 未披露
更多>>
from June 30, 2019 to September 30, 2019 Sale of common stock, net of issuance costs of $2,079 Sale of pre-funded warrants Repurchase of shares of common stock
2019-09-30
2019-09-03 4599.89 未披露 定期报告 2019-08-15
2019-08-14 4600.13 未披露 定期报告 2019-08-01
2019-08-14 3539.89 未披露
更多>>
From March 31, 2019 to June 30, 2019 Repurchase of shares of common stock
2019-06-30
2019-05-13 3540.56 未披露 定期报告 2019-05-01
2019-05-13 3541.49 未披露
更多>>
From December 31, 2018 to March 31, 2019 Repurchase of shares of common stock
2019-03-31
2019-03-13 3542.29 未披露 定期报告 2019-02-15
2019-03-13 3543.25 未披露
更多>>
from December 31, 2017 to September 30, 2018 Conversion of units into shares of common stock Repurchase of common units/ shares of common stock Issuance of common stock upon initial public offering, net of issuance costs of $4,592
2018-09-30
2018-08-10 3543.25 未披露 定期报告 2018-08-01
2018-08-10 3544.48 未披露
更多>>
from December 31, 2017 to June 30, 2018 Conversion of units into shares of common stock Repurchase of common units/ shares of common stock Issuance of common stock upon initial public offering, net of issuance costs of $4,592
2018-06-30
2018-05-10 3546.20 未披露 定期报告 2018-05-01
2018-05-10 3547.69 未披露
更多>>
from December 31, 2017 to March 31, 2018 Conversion of units into shares of common stock Repurchase of common units/ shares of common stock Issuance of common stock upon initial public offering, net of issuance costs of $4,592
2018-03-31
2018-03-29 3547.69 未披露 定期报告 2018-03-15
2018-01-29 3415.10 未披露
更多>>
1.Common stock offered 7,812,500 shares 2.The number of shares outstanding after this offering is based on 26,338,522 shares of our common stock outstanding as of September 30, 2017
2018-01-26
2018-03-29 1943.86 1180.04
更多>>
from December 31, 2016 to December 31, 2017 Issuance of Series A common units in exchange for redeemable preferred units Issuance of Series 2 senior preferred units, Issuance of Series 1 senior preferred units, net of issuance costs of $500 and tranche right of $459 Issuance of junior preferred units in redemption of Class D non-controlling interest in Solid GT Issuance of Series B common units in exchange for Series A common units Issuance of Series D common units in exchange for Series A common units Issuance of Series C common units in exchange for Class B non-controlling interest in Solid GT Issuance of Series D common units in exchange for Class C non-controlling interest in Solid GT Issuance of Series D common units
2017-12-31
2017-12-29 1924.10 691.44
更多>>
from December 31, 2016 to September 30, 2017 Issuance of Series A common units in exchange for redeemable preferred units Issuance of Series 1 senior preferred units, net of issuance costs of $500 and tranche right of $459 Issuance of junior preferred units in redemption of Class D non-controlling interest in Solid GT Issuance of Series B common units in exchange for Series A common units Issuance of Series D common units in exchange for Series A common units Issuance of Series C common units in exchange for Class B non-controlling interest in Solid GT Issuance of Series D common units in exchange for Class C non-controlling interest in Solid GT Issuance of Series D common units
2017-09-30
From December 31,2022 to December 31,2023 Vesting of restricted stock units Sale of common stock net of issuance costs of $76 Issuance of common stock in connection with employee stock purchase plan
From June 30, 2023 to September 30, 2023 Vesting of restricted stock units
From March 31, 2023 to June 30, 2023 Vesting of restricted stock units Sales of common stock, net of issuance costs of $65 Issuance of common stock in connection with employee stock purchase plan
From December 31, 2022 to March 31, 2023 Vesting of restricted stock units
From December 31, 2021 to December 31, 2022 Sale of common stock,net of issuance costs of $2,449 Issuance of ESPP shares Vesting of restricted stock units Issuance of shares in connection with acquisition
On October 27, 2022 (the “Effective Date”), Solid Biosciences Inc. (the “Company”) filed a Certificate of Amendment to the Company’s Certificate of Incorporation with the Secretary of State of the State of Delaware (the “Certificate of Amendment”), which effected, as of 5:00 p.m. Eastern Time, on the Effective Date, a one-for-15 reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding common stock, $0.001 par value per share (the “Common Stock”).
From March 31, 2022 to June 30, 2022 Vesting of restricted stock units Issuance of ESPP shares
From December 31, 2021 to March 31, 2022 Vesting of restricted stock units
From December 31, 2020 to December 31, 2021 Sale of common stock, net of issuance costs of $8,872 Exercise of common stock options Issuance of ESPP shares Vesting of restricted stock units Forfeiture of restricted stock awards Unrealized loss on available-for-sale securities
From June 30, 2021 to September 30, 2021 Exercise of stock options Forfeiture of restricted stock awards
From March 31, 2021 to June 30, 2021 Exercise of stock options Vesting of restricted stock units Forfeiture of restricted stock awards
From December 31, 2020 To March 31, 2021 Sale of common stock, net of issuance costs of $8,872,000 Exercise of stock options Vesting of restricted stock units Forfeiture of restricted stock awards
1.Common stock offered by the company 21,739,131 shares. 2.The number of shares of common stock to be outstanding after this offering is based on 85,138,567 shares of common stock outstanding as of March 15, 2021.
From December 31, 2019 to December 31, 2020 Sale of common stock, net of issuance costs of $3,790 Issuance of common stock, to a related party, in connection with the Stock Purchase Agreement Vesting of restricted stock units Forfeiture of restricted stock awards
From June 30, 2020 to September 30, 2020 Vesting of restricted stock units Forfeiture of restricted stock awards
From March 31, 2020 to June 30, 2020 Forfeiture of restricted stock awards
From December 31, 2019 to March 31, 2020 Vesting of restricted stock units Forfeiture of restricted stock awards
From December 31, 2018 to December 31, 2019 Sale of common stock, net of issuance costs of $2,102 Sale of pre-funded warrants Forfeiture of restricted stock awards
from June 30, 2019 to September 30, 2019 Sale of common stock, net of issuance costs of $2,079 Sale of pre-funded warrants Repurchase of shares of common stock
From March 31, 2019 to June 30, 2019 Repurchase of shares of common stock
From December 31, 2018 to March 31, 2019 Repurchase of shares of common stock
from December 31, 2017 to September 30, 2018 Conversion of units into shares of common stock Repurchase of common units/ shares of common stock Issuance of common stock upon initial public offering, net of issuance costs of $4,592
from December 31, 2017 to June 30, 2018 Conversion of units into shares of common stock Repurchase of common units/ shares of common stock Issuance of common stock upon initial public offering, net of issuance costs of $4,592
from December 31, 2017 to March 31, 2018 Conversion of units into shares of common stock Repurchase of common units/ shares of common stock Issuance of common stock upon initial public offering, net of issuance costs of $4,592
1.Common stock offered 7,812,500 shares 2.The number of shares outstanding after this offering is based on 26,338,522 shares of our common stock outstanding as of September 30, 2017
from December 31, 2016 to December 31, 2017 Issuance of Series A common units in exchange for redeemable preferred units Issuance of Series 2 senior preferred units, Issuance of Series 1 senior preferred units, net of issuance costs of $500 and tranche right of $459 Issuance of junior preferred units in redemption of Class D non-controlling interest in Solid GT Issuance of Series B common units in exchange for Series A common units Issuance of Series D common units in exchange for Series A common units Issuance of Series C common units in exchange for Class B non-controlling interest in Solid GT Issuance of Series D common units in exchange for Class C non-controlling interest in Solid GT Issuance of Series D common units
from December 31, 2016 to September 30, 2017 Issuance of Series A common units in exchange for redeemable preferred units Issuance of Series 1 senior preferred units, net of issuance costs of $500 and tranche right of $459 Issuance of junior preferred units in redemption of Class D non-controlling interest in Solid GT Issuance of Series B common units in exchange for Series A common units Issuance of Series D common units in exchange for Series A common units Issuance of Series C common units in exchange for Class B non-controlling interest in Solid GT Issuance of Series D common units in exchange for Class C non-controlling interest in Solid GT Issuance of Series D common units